tert-Butyl 3-(1-amino-3-methoxy-3-oxopropyl)piperidine-1-carboxylate

Catalog No. :
ACPAGY569
CAS No. :
1823506-74-6
Molecular Formula :
C14H26N2O4
Molecular Weight :
286.37

IUPAC Name:tert-butyl 3-(1-amino-3-methoxy-3-oxopropyl)piperidine-1-carboxylate

tert-Butyl 3-(1-amino-3-methoxy-3-oxopropyl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$79.00Login to see priceIn stockInquiry
1g95%$212.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(1-amino-3-methoxy-3-oxopropyl)piperidine-1-carboxylate
IUPAC Nametert-butyl 3-(1-amino-3-methoxy-3-oxopropyl)piperidine-1-carboxylate
Molecular FormulaC14H26N2O4
Molecular Weight286.37
SMILESO=C(N1CC(C(N)CC(OC)=O)CCC1)OC(C)(C)C
InChI KeyIWRUBJIHFBNLPN-UHFFFAOYSA-N
Synonym3-Piperidinepropanoic acid, β-amino-1-[(1,1-dimethylethoxy)carbonyl]-, methyl ester;tert-Butyl 3-(1-amino-3-methoxy-3-oxopropyl)piperidine-1-carboxylate;Methyl b-amino-1-Boc-3-piperidinepropanoate
CAS No.1823506-74-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACPAGY569 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACESHO458 route compound structure diagram
    ACESHO458891494-65-8 In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACPAGY569 route product structure diagram
    ACPAGY5691823506-74-6 In Stock
Inquiry

2. ACPAGY569 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPAGY569 route product structure diagram
    ACPAGY5691823506-74-6 In Stock
Inquiry

Comments (0)